generic drugs

(iStock)
August 6, 2020

Study finds Medicare Part D favors generic drugs over brand-name counterparts

Contrary to previous media reports, a new study led by Vanderbilt University Medical Center researchers finds that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts.

By Jake Lowary
July 1, 2019

Study shows some generics can cost Medicare recipients more than brand-name drugs

Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.

By Jake Lowary